Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Evelo Biosciences, Inc. | evlo-20201231.htm |
| EX-32.2 - EX-32.2 - Evelo Biosciences, Inc. | a12312020exhibit322.htm |
| EX-31.2 - EX-31.2 - Evelo Biosciences, Inc. | a12312020exhibit312.htm |
| EX-31.1 - EX-31.1 - Evelo Biosciences, Inc. | a12312020exhibit311.htm |
| EX-23.1 - EX-23.1 - Evelo Biosciences, Inc. | a12312020exhibit231.htm |
| EX-10.17 - EX-10.17 - Evelo Biosciences, Inc. | a12312020exhibit1017.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Balkrishan (Simba) Gill, Ph.D., President and Chief Executive Officer of Evelo Biosciences, Inc. (the “Company”), hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
(1)The Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2020 (the “Report”) fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: March 9, 2021 | By: | /s/ Balkrishan (Simba) Gill, Ph.D. | |||||||||||||||
| Balkrishan (Simba) Gill, Ph.D. | |||||||||||||||||
| President and Chief Executive Officer | |||||||||||||||||
| (Principal Executive Officer and Principal Financial Officer) | |||||||||||||||||